Your browser doesn't support javascript.
loading
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies.
Kikuchi, Taku; Tsukada, Nobuhiro; Kunisada, Kodai; Nomura-Yogo, Moe; Oda, Yuki; Sato, Kota; Takei, Tomomi; Ogura, Mizuki; Abe, Yu; Suzuki, Kenshi; Ishida, Tadao.
Afiliación
  • Kikuchi T; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan. taku_k_1123@mac.com.
  • Tsukada N; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Kunisada K; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Nomura-Yogo M; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Oda Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Sato K; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Takei T; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Ogura M; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Abe Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Ishida T; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
Ann Hematol ; 102(12): 3489-3497, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37668787
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania